Biotech is having a good year, though you wouldn't necessarily know it from how investors are treating positive clinical data. Local authorities and relevant stakeholders are closely monitoring the situation as fresh developments unfold on the ground. Officials noted that further verified updates and administrative measures will be shared following a detailed review.